Aline Sprikkelman

Aline Sprikkelman is a clinician-scientist whose goal is to improve early diagnosis and prevention of atopic dermatitis/eczema and the subsequent development of allergic multimorbidity, and to optimize treatment of eczema.

As a pediatric allergist, she focuses on children with severe chronic allergic diseases.

She is the founder and chair of the Pediatric Allergy Center of the University Medical Center Groningen (UMCG), The Netherlands. 

She is the supervisor of the clinical fellowship Pediatric Allergy in the UMCG – Amsterdam-UMC cluster and supervisor of PhD students. 

In her research at current, she investigates the epidemiology and risk factors (clinical, immunological, genetics) of early onset infant eczema and allergic multimorbidity as well as diagnostic skin tape stripping for early biomarkers as predictor for eczema in the Lifelines and Lifelines Next birth cohort.  Furthermore, she is working on the development of a model that predict the onset and course of eczema and the subsequent development of allergic diseases throughout childhood and adolescence, with the ultimate aim to identify the infant at risk and improve preventive strategies. She was involved as PI in studies investigating the role of microbial modulation in the management of eczema in infancy, and of the Dutch Europrevall birth cohort and iFAAM cohort.

Besides her clinical and scientific engagements, she was Board Member of the Pediatric Section, European Academy of Allergy and Clinical Immunology.  At current she is Board Member of the Pediatric Allergy Section of the Dutch Society of Pediatrics and of the Groningen Research Institute for Asthma and COPD.